*001242521
*00520250613114954.0
*007ta
*008130319uuuuuuuuuno                 0eng d
*00901881cas a2200385 c 4500
*019  $bjp
*022  $a1726-4898
*022  $y0802-8753
*035  $a(EXLNZ-47BIBSYS_NETWORK)990301162604702201
*035  $a(NO-TrBIB)030116260
*035  $a030116260-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*060 4$aQU 55
*060 4$aW 1
*060 4$aW1
*24500$aGuidelines for ATC classification and DDD assignment ...
*260  $aOslo$bWHO Collaborating Centre for Drug Statistics Methodology
*310  $aÅrlig
*500  $aSenere medutgiver: Norwegian Institute of Public Health
*500  $aTittelvariant: Guidelines for ATC and DDD
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2023-11-30
*580  $aSammenslåing av: Guidelines for ATC classification : a co-publication between: WHO Collaborating Centre for Drug Statistics Methodology, Nordic Council on Medicines; og Guidelines for DDD
*650 2$aDrug Utilization$_28118300
*650 2$aPharmacology$_13842600
*7102 $aNasjonalt folkehelseinstitutt$0(NO-TrBIB)2014319$_11465300
*7102 $aWHO Collaborating Centre for Drug Statistics Methodology$0(NO-TrBIB)90269110$_45720300
*7400 $aGuidelines for ATC and DDD
*78014$tGuidelines for ATC classification : a co-publication between: WHO Collaborating Centre for Drug Statistics Methodology, Nordic Council on Medicines$g5(1994)$w999114458034702201
*78014$tGuidelines for DDD$g2(1993)$w999114458704702201
*7870 $tLineamientos para clasificación ATC y la asignación de DDD$w990301192274702201
*7870 $tRichtlinien für die ATC-Klassifikation und die DDD-Festlegung$w990301193674702201
*85641$3Fulltekst$uhttps://www.nb.no/search?q=seriestitleid:"oai:nb.bibsys.no:990301162604702202"&mediatype=tidsskrift$yNettbiblioteket$zSøke-URL
*86630$a2003- .$90183300$822113127670002202
*901  $a80
*999  $aoai:nb.bibsys.no:990301162604702202$b2021-11-14T20:00:08Z$z990301162604702202
^